Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy (Q68289938)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 12, 1991

edit

Language	Label	Description	Also known as
English	Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy	scientific article published on January 12, 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

title

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

main subject

chemotherapy

1 reference

based on heuristic

inferred from title

author name string

G. K. Rivera

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

S. C. Raimondi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

M. L. Hancock

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

F. G. Behm

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

C. H. Pui

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

M. Abromowitch

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

J. Mirro

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

J. S. Ochs

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

A. T. Look

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

D. L. Williams

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1670723

retrieved

25 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

12 January 1991

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1670723

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1670723

retrieved

25 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0140673691907336?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

https://api.elsevier.com/content/article/PII:0140673691907336?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

published in

The Lancet

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

volume

337

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

issue

8733

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

page(s)

61-66

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

cites work

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Results and significance of six randomized trials in four consecutive ALL-BFM studies

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

A direct bone marrow chromosome technique for acute lymphoblastic leukemia

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

The cytogenetics of childhood leukemia: clinical and biologic implications

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemia

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Age at diagnosis in childhood acute lymphoblastic leukemia

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group review

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome.

series ordinal

23

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

series ordinal

28

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Cyclophosphamide and bone marrow transplantation

series ordinal

30

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity

series ordinal

31

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)90733-6

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

retrieved

25 October 2022

Identifiers

DOI

10.1016/0140-6736(91)90733-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

PubMed publication ID

1670723

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1670723

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68289938&oldid=1757569881"